Alamar Biosciences, Inc (ALMR) insider trading
Every open-market stock purchase and sale by Alamar Biosciences, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders bought $8M over the last 12 months (2 buys).
- Last insider buy: Nicholas Naclerio (Insider), $4M, 5 months ago.
Last 12 months: insiders bought $8M (2 buys) and sold $0 (0 sales). Last close $34.85 on Sep 18, 2026.
Recent ALMR insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Sep 14, 2026 | John L. Brottem (General Counsel) | Bought (not open market) | — |
| Sep 14, 2026 | John L. Brottem (General Counsel) | Bought (not open market) | — |
| Sep 1, 2026 | Robert P Ragusa (Insider) | Bought (not open market) | — |
| Sep 1, 2026 | Robert P Ragusa (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | Nicholas Naclerio (Insider) | Bought | $4M |
| Apr 20, 2026 | Illumina Innovation Fund II GP L.L.C. (Insider) | Bought | $4M |
| Apr 20, 2026 | Nicholas Naclerio (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | Nicholas Naclerio (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | Nicholas Naclerio (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | Nicholas Naclerio (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | Justin J. McAnear (CFO) | Bought (not open market) | — |
| Apr 20, 2026 | Timothy Ogden White (President) | Bought (not open market) | — |
| Apr 20, 2026 | Rebecca Chambers (Insider) | Bought (not open market) | — |
| Apr 20, 2026 | Justin J. McAnear (CFO) | Bought (not open market) | — |
| Apr 20, 2026 | Timothy Ogden White (President) | Bought (not open market) | — |
| Apr 20, 2026 | Timothy Ogden White (President) | Bought (not open market) | — |
| Apr 20, 2026 | Timothy Ogden White (President) | Bought (not open market) | — |
| Apr 20, 2026 | Timothy Ogden White (President) | Bought (not open market) | — |
| Apr 20, 2026 | Yuling Luo (CEO) | Bought (not open market) | — |
| Apr 20, 2026 | Yuling Luo (CEO) | Bought (not open market) | — |
| Apr 20, 2026 | Yuling Luo (CEO) | Bought (not open market) | — |
| Apr 20, 2026 | Yuling Luo (CEO) | Bought (not open market) | — |
| Apr 20, 2026 | Yuling Luo (CEO) | Bought (not open market) | — |
| Apr 20, 2026 | Yuling Luo (CEO) | Bought (not open market) | — |
| Apr 20, 2026 | Timothy Ogden White (President) | Bought (not open market) | — |
Who's trading ALMR
- John L. Brottem, General Counsel: other filings, last Sep 14, 2026
- Robert P Ragusa, Insider: other filings, last Sep 1, 2026
- Shiping Chen, COO: other filings, last Apr 20, 2026
- Illumina Innovation Fund II GP L.L.C., Insider: bought $4M (1 buy), last Apr 20, 2026
- Yuling Luo, CEO: other filings, last Apr 20, 2026
- Justin J. McAnear, CFO: other filings, last Apr 20, 2026
- Nicholas Naclerio, Insider: bought $4M (1 buy), last Apr 20, 2026
- Qiming Corporate GP VI Ltd., Insider: other filings, last Apr 20, 2026
- Timothy Ogden White, President: other filings, last Apr 20, 2026
- Frank Witney, Insider: other filings, last Apr 20, 2026
- Rebecca Chambers, Insider: other filings, last Apr 20, 2026
Get free alerts when an insider at Alamar Biosciences, Inc files a new trade →